The ability of NT-proBNP to detect chronic heart failure and predict all-cause mortality is higher in elderly Chinese coronary artery disease patients with chronic kidney disease

References

• JanuzziJLJrCamargoCAAnwaruddinSThe N-terminal Pro- BNP Investigation of Dyspnea in the Emergency department (PRIDE) studyAm J Cardiol200595894895415820160
   PubMed Web of Science ®Google Scholar
• AnavekarNSMcMurrayJJVelazquezEJRelation between renal dysfunction and cardiovascular outcomes after myocardial infarctionN Engl J Med2004351131285129515385655
   PubMed Web of Science ®Google Scholar
• McAlisterFAEzekowitzJTonelliMArmstrongPWRenal insufficiency and heart failure: prognostic and therapeutic implications from a prospective cohort studyCirculation200410981004100914769700
   PubMed Web of Science ®Google Scholar
• DeFilippiCvan KimmenadeRRPintoYMAmino-terminal pro- B-type natriuretic peptide testing in renal diseaseAm J Cardiol20081013A828818243865
   PubMed Web of Science ®Google Scholar
• VargheseKCherianGAbrahamUTHayatNJJohnyKVPredictors of coronary disease in patients with end stage renal diseaseRen Fail200123679780611777319
   PubMed Web of Science ®Google Scholar
• BaigentCBurburyKWheelerDPremature cardiovascular disease in chronic renal failureLancet2000356922414715210963260
   PubMed Web of Science ®Google Scholar
• GardnerRSChongKSO’MearaEJardineAFordIMcDonaghTARenal dysfunction, as measured by the modification of diet in renal disease equations, and outcome in patients with advanced heart failureEur Heart J200728243027303317967819
   PubMed Web of Science ®Google Scholar
• BruchCFischerCSindermannJStypmannJBreithardtGGradausRComparison of the prognostic usefulness of n-terminal pro–brain natriuretic peptide in patients with heart failure with versus without chronic kidney diseaseAm J Cardiol2008102446947418678308
   PubMed Web of Science ®Google Scholar
• HartmannFPackerMCoatsAJPrognostic impact of plasma N-terminal pro-brain natriuretic peptide in severe chronic congestive heart failure: a substudy of the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) TrialCirculation2004110131780178615381643
   PubMed Web of Science ®Google Scholar
• BraunwaldEAntmanEMBeasleyJWACC/AHA guidelines for the management of patients with unstable angina and non–ST-segment elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients with Unstable Angina)J Am Coll Cardiol2000363970106210987629
   PubMed Web of Science ®Google Scholar
• RyanTJAntmanEMBrooksNH1999 Update: ACC/AHA guidelines for the management of patients with acute myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction)J Am Coll Cardiol199934389091110483976
   PubMed Web of Science ®Google Scholar
• FoxKGarciaMAArdissinoDTask Force on the Management of Stable Angina Pectoris of the European Society of Cardiology; ESC Committee for Practice Guidelines (CPG)Guidelines on the management of stable angina pectoris: executive summary: The Task Force on the Management of Stable Angina Pectoris of the European Society of CardiologyEur Heart J200627111341138116735367
   PubMed Web of Science ®Google Scholar
• MaYCZuoLChenJHModified glomerular filtration rate estimating equation for Chinese patients with chronic kidney diseaseJ Am Soc Nephrol200617102937294416988059
   PubMed Web of Science ®Google Scholar
• National Kidney FoundationK/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratificationAm J Kidney Dis2002392 Suppl 1S1S26611904577
   PubMed Web of Science ®Google Scholar
• FusterVRydénLECannomDSAmerican College of Cardiology/American Heart Association Task Force on Practice Guidelines; European Society of Cardiology Committee for Practice Guidelines; European Heart Rhythm Association; Heart Rhythm SocietyACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm SocietyCirculation20061147e257e35416908781
   PubMed Web of Science ®Google Scholar
• DicksteinKCohen-SolalAFilippatosGESC Committee for Practice Guidelines (CPG)ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008Eur Heart J200829192388244218799522
   PubMed Web of Science ®Google Scholar
• JohnsonESThorpMLYangXCharansonneyOLSmithDHPredicting renal replacement therapy and mortality in CKDAm J Kidney Dis200750455956517900455
   PubMed Web of Science ®Google Scholar
• SPSS IncSPSS Missing Values™ 17.0ArmonkIBM Corporation2007
   Google Scholar
• RichardsMNichollsMGEspinerEAChristchurch Cardioendocrine Research Group; Australia-New Zealand Heart Failure GroupComparison of B-type natriuretic peptides for assessment of cardiac function and prognosis in table ischemic heart diseaseJ Am Coll Cardiol2006471526016386664
   PubMed Web of Science ®Google Scholar
• GoeiDSchoutenOBoersmaEInfluence of renal function on the usefulness of N-terminal pro-B-type natriuretic peptide as a prognostic cardiac risk marker in patients undergoing noncardiac vascular surgeryAm J Cardiol2008101112212618157978
   PubMed Web of Science ®Google Scholar
• PfisterRDiedrichsHSchiedermairAPrognostic impact of NT-proBNP and renal function in comparison to contemporary multimarker risk scores in heart failure patientsEur J Heart Fail200810331532018304872
   PubMed Web of Science ®Google Scholar
• DasSRAbdullahSMLeonardDAssociation between renal function and circulating levels of natriuretic peptides (from the Dallas Heart Study)Am J Cardiol2008102101394139818993162
   PubMed Web of Science ®Google Scholar
• HerrmannZUhlWSteinbergHWDworschackRThe influence of renal function on NT-proBNP levels in various disease groupsClin Lab20034911–1264965614651336
   PubMedGoogle Scholar
• van KimmenadeRRJanuzziJLJrBakkerJARenal clearance of B-type natriuretic peptide and amino terminal pro-B-type natriuretic peptide: a mechanistic study in hypertensive subjectsJ Am Coll Cardiol2009531088489019264247
   PubMed Web of Science ®Google Scholar
• LeeJEChoiSYHuhWN-terminal pro-brain natriuretic peptide levels predict left ventricular systolic function in patients with chronic kidney diseaseJ Korean Med Sci200924Suppl 1S63S6819194564
   PubMed Web of Science ®Google Scholar
• KragelundCGrønningBKøberLHildebrandtPSteffensenRN-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart diseaseN Engl J Med2005352766667515716560
   PubMed Web of Science ®Google Scholar
• JamesSKLindahlBSiegbahnAN-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease: a Global Utilization of Strategies To Open occluded arteries (GUSTO)-IV substudyCirculation2003108327528112847065
   PubMed Web of Science ®Google Scholar